Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Parnetti

Showing results (111-120 of 117) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 117 results.
Neurobiology of Disease|March 24, 2009
Cerebrospinal fluid beta-glucocerebrosidase activity is reduced in Dementia with Lewy BodiesL Parnetti, C Balducci, L Pierguidi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 15, 2016
The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies designL Bonanni, A Cagnin, F Agosta, et al.
European Journal of Neurology|February 4, 2020
Time trends, frequency, characteristics and prognosis of short-duration transient global amnesiaM Romoli, M A Tuna, L Li, et al.
European Journal of Neurology|November 7, 2019
Italian consensus recommendations for a biomarker-based aetiological diagnosis in mild cognitive impairment patientsM Boccardi, V Nicolosi, C Festari, et al.
Annals of Clinical Biochemistry|April 4, 2009
A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's diseaseN A Verwey, W M van der Flier, K Blennow, et al.
Neurology|February 4, 2012
Age and diagnostic performance of Alzheimer disease CSF biomarkersN Mattsson, E Rosén, O Hansson, et al.
Journal of Internal Medicine|March 5, 2016
Clinical and biomarker profiling of prodromal Alzheimer's disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a 'European ADNI study'S Galluzzi, M Marizzoni, C Babiloni, et al.
Pageof 12

Showing results (111-120 of 117) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 117 results.
Neurobiology of Disease|March 24, 2009
Cerebrospinal fluid beta-glucocerebrosidase activity is reduced in Dementia with Lewy BodiesL Parnetti, C Balducci, L Pierguidi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 15, 2016
The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies designL Bonanni, A Cagnin, F Agosta, et al.
European Journal of Neurology|February 4, 2020
Time trends, frequency, characteristics and prognosis of short-duration transient global amnesiaM Romoli, M A Tuna, L Li, et al.
European Journal of Neurology|November 7, 2019
Italian consensus recommendations for a biomarker-based aetiological diagnosis in mild cognitive impairment patientsM Boccardi, V Nicolosi, C Festari, et al.
Annals of Clinical Biochemistry|April 4, 2009
A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's diseaseN A Verwey, W M van der Flier, K Blennow, et al.
Neurology|February 4, 2012
Age and diagnostic performance of Alzheimer disease CSF biomarkersN Mattsson, E Rosén, O Hansson, et al.
Journal of Internal Medicine|March 5, 2016
Clinical and biomarker profiling of prodromal Alzheimer's disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a 'European ADNI study'S Galluzzi, M Marizzoni, C Babiloni, et al.
Pageof 12